344 filings
8-K
ACER
Acer Therapeutics Inc.
20 Nov 23
Completion of Acquisition or Disposition of Assets
4:26pm
8-K
ACER
Acer Therapeutics Inc.
8 Nov 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
ACER
Acer Therapeutics Inc.
2 Nov 23
Entry into a Material Definitive Agreement
8:49am
8-K
ACER
Acer Therapeutics Inc.
31 Aug 23
Voting and Support Agreement
9:26am
8-K
ACER
Acer Therapeutics Inc.
14 Aug 23
Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
1zy dcp5asbr4dxo5
26 Jun 23
Entry into a Material Definitive Agreement
9:00am
8-K
o6k84amjz2 5rftg
7 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
e2h3nalnes 0j
22 May 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
okibhk
15 May 23
Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
5:10pm
8-K
g9a 4mwg2w60
3 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:33pm
8-K
8zm4 uk08cnq31
1 May 23
Acer Therapeutics Announces OLPRUVAâ„¢ Commercial Launch Progressing Ahead of Schedule
9:00am
8-K
o1g5sx0y26
27 Apr 23
Other Events
6:06am
8-K
b7o6lqpkv
27 Mar 23
Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
8-K
rreozb
22 Mar 23
Acer Therapeutics Announces $2.675 Million Registered Direct Offering
4:01pm
8-K
gy33j6bvi 0z
17 Mar 23
Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial
9:00am
8-K
hzs8i xcxq
15 Mar 23
Other Events
9:00am
8-K
b8jxd4hbe25dswsh
13 Feb 23
Topline trial results expected mid-March 2023
9:00am
8-K
cncksm
7 Feb 23
Other Events
4:01pm
8-K
dhldwzl tplnz
1 Feb 23
Regulation FD Disclosure
4:03pm
8-K
syi1 cso8cmu4bwag
31 Jan 23
Entry into a Material Definitive Agreement
9:25am